For IPO Boutique's "scale of 1 to 5" BUY rating on Dermtech International, and our comprehensive analysis, click "Buy Market Research".
About Dermtech International (adapted from Dermtech International prospectus): They are an emerging growth diagnostics company developing and marketing novel non-invasive gene expression tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "DMTK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?
